While we did document slower tumor growth and ELISpot reactivity to the immunizing survivin peptides tested in this study, future experiments in this model should include a demonstration of the presence of tumor-infiltrating lymphocytes presumably responsible for the effects on tumor growth. Here, BIRC5 is linked to neoplasm.